As of December 31, 2025, Xlife Sciences Ltd. has 5.77M shares outstanding.
| Shares Outstanding | 5.77M |
As of December 31, 2025, Xlife Sciences Ltd. maintains a current ratio of 0.10, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.10 |
| Quick Ratio | 0.07 |
| Debt / Equity | 16.11 |
As of December 31, 2025, Xlife Sciences Ltd. holds 1.05M in cash and equivalents against 60.00M in total debt, resulting in a net debt position of 59.48M. Total book value stands at 286.53M, with working capital of -13.38M providing operational flexibility.
| Cash & Cash Equivalents | 1.05M |
| Total Debt | 60.00M |
| Net Debt | 59.48M |
| Equity (Book Value) | 286.53M |
| Book Value Per Share | 49.68 |
| Working Capital | -13.38M |
Already premium?